EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Low‐Cost New Glaucoma Drainage Device in Indonesia: One Year Follow‐Up of 252 Subjects

Virna Dwi Oktariana Asrory iD, William H Morgan

Clinical & Experimental Ophthalmology · 2025

DOI: 10.1111/ceo.14509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Ophthalmology, 2025. Verfasst von Virna Dwi Oktariana Asrory und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Hauptthemen laut MEDLINE: Glaucoma Drainage Implants, Intraocular Pressure, Glaucoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To evaluate the early efficacy and safety of a new polymethyl methacrylate 200 mm 2 non‐valved glaucoma drainage device (GDD) designed for Indonesian use over a 12 month period.

Methods

This was a prospective study following subjects with various forms of refractory glaucoma aged ≥ 7 years old followed for 12 months. The subjects had IOP measurements and biomicroscopy examination preoperatively and at 1, 3, 6 and 12 months timepoints. We noted anti‐glaucoma medication use and additional interventions during follow‐up. Success was defined as an IOP > 5 and ≤ 21 mmHg on no medications (complete) or medications (qualified).

Results

There were 252 subjects, 31% (79/252) primary glaucoma and 69% (173/252) secondary glaucoma. All primary glaucoma had previous surgery. The majority of secondary glaucoma was post‐vitrectomy and silicone oil insertion 35.6% (62/174). The mean pre‐op IOP was 36.8 ± 12.2 mmHg and the 12 months post op IOP was 14.2 ± 6.6 mmHg. The qualified success rate was 89% at 1 year and the complete success was 57%. Mean medication use dropped from 3.5 to 1.3. Certain subtypes (Silicone oil and POAG) appeared to experience greater IOP reduction, however they also had greater preoperative IOP.

Conclusion

This new GDD has comparable IOP lowering outcomes compared with other non‐valved glaucoma drainage devices during 1 year follow up with similar complication rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glaucoma Drainage ImplantsIntraocular PressureGlaucomaHumansIndonesiaMaleFemaleProspective StudiesFollow-Up StudiesMiddle AgedAgedAdultTonometry, OcularChildAdolescentYoung AdultVisual AcuityAged, 80 and overTreatment OutcomeProsthesis DesignPolymethyl Methacrylate

Stichwörter der Autor:innen

glaucoma drainage deviceprimary glaucomasecondary glaucomavirna glaucoma implant

Substanzen

Polymethyl Methacrylate

Autor:innen und Institutionen

  • Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
  • Lions Eye Institute, University of Western Australia, Perth, Australia.

ORCID-Profile: Virna Dwi Oktariana Asrory

Zitieren

APA

Asrory, V. D. O., & Morgan, W. H. (2025). Low‐Cost New Glaucoma Drainage Device in Indonesia: One Year Follow‐Up of 252 Subjects. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14509

Vancouver

Asrory VDO, Morgan WH. Low‐Cost New Glaucoma Drainage Device in Indonesia: One Year Follow‐Up of 252 Subjects. Clinical & Experimental Ophthalmology. 2025. doi:10.1111/ceo.14509

BibTeX
@article{Asrory2025,
  author = {Asrory, Virna Dwi Oktariana and Morgan, William H},
  title = {Low‐Cost New Glaucoma Drainage Device in Indonesia: One Year Follow‐Up of 252 Subjects},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2025},
  doi = {10.1111/ceo.14509}
}
Kostenlos starten →